If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Of the 8,162,992 ordinary shares reported as beneficially owned with sole voting and dispositive power, (i) 135,000 ordinary shares reported are issuable upon exercise of options for the purchase of ordinary shares, and (ii) 376,468 ordinary shares are issuable upon exercise of warrants for the purchase of ordinary shares, each of which are exercisable within 60 days of August 12, 2025. (2) Row 13 is calculated based on 66,443,962 ordinary shares, which includes (i) 65,932,494 ordinary shares outstanding as of July 17, 2025, (ii) 135,000 ordinary shares issuable upon exercise of options for the purchase of ordinary shares, which are exercisable within 60 days of August 12, 2025 and (iii) 376,468 ordinary shares issuable upon exercise of warrants for the purchase of ordinary shares, which are exercisable within 60 days of August 12, 2025.


SCHEDULE 13D


 
Nikolaus Senn
 
Signature:/s/ Nikolaus Senn
Name/Title:Individual
Date:08/12/2025